These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 32588980)
1. Humanized Mouse Models for Evaluation of PSC Immunogenicity. Hermsen J; Brown ME Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e113. PubMed ID: 32588980 [TBL] [Abstract][Full Text] [Related]
2. Pluripotent stem cells and tolerance induction in organ transplantation. Imberti B; Monti M; Casiraghi F Curr Opin Organ Transplant; 2015 Feb; 20(1):86-93. PubMed ID: 25522138 [TBL] [Abstract][Full Text] [Related]
3. Precise immune tolerance for hPSC derivatives in clinical application. Zhu W; Li M; Wu Y; Hu B Cell Immunol; 2018 Apr; 326():15-23. PubMed ID: 28866278 [TBL] [Abstract][Full Text] [Related]
4. Dual use of hematopoietic and mesenchymal stem cells enhances engraftment and immune cell trafficking in an allogeneic humanized mouse model of head and neck cancer. Morton JJ; Keysar SB; Perrenoud L; Chimed TS; Reisinger J; Jackson B; Le PN; Nieto C; Gomez K; Miller B; Gao D; Somerset H; Wang XJ; Jimeno A Mol Carcinog; 2018 Nov; 57(11):1651-1663. PubMed ID: 30129680 [TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of putative hematopoietic stem cells derived from human pluripotent stem cells. Hexum MK; Tian X; Kaufman DS Methods Mol Biol; 2011; 767():433-47. PubMed ID: 21822894 [TBL] [Abstract][Full Text] [Related]
7. A Humanized Mouse Model Generated Using Surplus Neonatal Tissue. Brown ME; Zhou Y; McIntosh BE; Norman IG; Lou HE; Biermann M; Sullivan JA; Kamp TJ; Thomson JA; Anagnostopoulos PV; Burlingham WJ Stem Cell Reports; 2018 Apr; 10(4):1175-1183. PubMed ID: 29576539 [TBL] [Abstract][Full Text] [Related]
8. Immunology of stem cells and cancer stem cells. Yang XF Cell Mol Immunol; 2007 Jun; 4(3):161-71. PubMed ID: 17601370 [TBL] [Abstract][Full Text] [Related]
9. Advancing a Stem Cell Therapy for Age-Related Macular Degeneration. O'Neill HC; Limnios IJ; Barnett NL Curr Stem Cell Res Ther; 2020; 15(2):89-97. PubMed ID: 31854278 [TBL] [Abstract][Full Text] [Related]
10. The safety of human pluripotent stem cells in clinical treatment. Simonson OE; Domogatskaya A; Volchkov P; Rodin S Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342 [TBL] [Abstract][Full Text] [Related]
11. Beneath the sword of Damocles: regenerative medicine and the shadow of immunogenicity. Fairchild PJ; Horton C; Lahiri P; Shanmugarajah K; Davies TJ Regen Med; 2016 Dec; 11(8):817-829. PubMed ID: 27905261 [TBL] [Abstract][Full Text] [Related]
12. Progress and challenges in generating functional hematopoietic stem/progenitor cells from human pluripotent stem cells. Liu S; Xu Y; Zhou Z; Feng B; Huang H Cytotherapy; 2015 Apr; 17(4):344-58. PubMed ID: 25680303 [TBL] [Abstract][Full Text] [Related]
13. Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial. Brendel C; Rio P; Verhoeyen E Biochem Pharmacol; 2020 Apr; 174():113711. PubMed ID: 31726047 [TBL] [Abstract][Full Text] [Related]
15. CXCL12/CXCR4 Signaling Enhances Human PSC-Derived Hematopoietic Progenitor Function and Overcomes Early In Vivo Transplantation Failure. Reid JC; Tanasijevic B; Golubeva D; Boyd AL; Porras DP; Collins TJ; Bhatia M Stem Cell Reports; 2018 May; 10(5):1625-1641. PubMed ID: 29742393 [TBL] [Abstract][Full Text] [Related]
16. Human Pluripotent Stem Cell-Derived Neurons Are Functionally Mature In Vitro and Integrate into the Mouse Striatum Following Transplantation. Comella-Bolla A; Orlandi JG; Miguez A; Straccia M; García-Bravo M; Bombau G; Galofré M; Sanders P; Carrere J; Segovia JC; Blasi J; Allen ND; Alberch J; Soriano J; Canals JM Mol Neurobiol; 2020 Jun; 57(6):2766-2798. PubMed ID: 32356172 [TBL] [Abstract][Full Text] [Related]
17. Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations. Tang C; Drukker M Semin Immunopathol; 2011 Nov; 33(6):563-72. PubMed ID: 21479877 [TBL] [Abstract][Full Text] [Related]
18. Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards. Martin RM; Fowler JL; Cromer MK; Lesch BJ; Ponce E; Uchida N; Nishimura T; Porteus MH; Loh KM Nat Commun; 2020 Jun; 11(1):2713. PubMed ID: 32483127 [TBL] [Abstract][Full Text] [Related]
19. Embryonic stem cell-derived hematopoietic stem cells: challenges in development, differentiation, and immunogenicity. Thompson HL; Manilay JO Curr Top Med Chem; 2011; 11(13):1621-37. PubMed ID: 21446908 [TBL] [Abstract][Full Text] [Related]
20. Enhanced Therapeutic and Long-Term Dynamic Vascularization Effects of Human Pluripotent Stem Cell-Derived Endothelial Cells Encapsulated in a Nanomatrix Gel. Lee SJ; Sohn YD; Andukuri A; Kim S; Byun J; Han JW; Park IH; Jun HW; Yoon YS Circulation; 2017 Nov; 136(20):1939-1954. PubMed ID: 28972000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]